Perrigo | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
Abbott USD 6.53B 1.08B 2025-03
Bayer EUR 6.19B 1.57B 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Dr.Reddys Laboratories INR 13.03B 1.7B 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
J&J USD 38.47B 32.35B 2025-03
Merck USD 13.24B 1.35B 2024-12
Nestle CHF 5.56B 691M 2024-12
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Pfizer USD 1.04B 49M 2024-12
Prestige Brands USD 50.87M 666K 2024-12
Reckitt Benckiser GBP 880M 106M 2024-12
Sanofi 7.99B 550M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Teva Pharmaceutical Industries USD 3.3B 19M 2024-12
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12
Zoetis USD 1.98B 275M 2024-12



Perrigo Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.